Should Covid-19 vaccine manufacturers’ IP rights be waived?

Source: South China Morning PostAs Covid-19 vaccines are rolling out in wealthy countries but poorer ones struggle to get supplies, a debate over the rights of drug companies to guard their intellectual property is intensifying.The latest battleground was a council meeting at the World Trade Organization last week, where countries staked out their positions on whether rules needed to be suspended to get more doses made.The issue at stake is how to vaccinate billions of people around the world as quickly as possible. Many…Read More

Geef een reactie

Het e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *

Generated by Feedzy